The health tech market is projected to grow from $240 billion in 2022 to $1043 billion by 2030. Technologies like EHRs, e-prescribing, and telehealth aim to simplify tasks for providers and patients.

China’s focus on first or best-in-class oncology drugs and innovative R&D will help it to secure further licensing deals in 2026 and beyond.

Patients are often stabilised for years on somatostatin analogues; however, progression eventually necessitates ...

In 2015, CMS created a unique payment model that would allow practices to bill for care management, those services that help patients with a single high-risk condition or multiple chronic diagnoses ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...

BOSTON--(BUSINESS WIRE)--Ontada®, a McKesson business dedicated to oncology real-world data and evidence, clinical education, and point of care technologies, today announced that it is collaborating ...

Flatiron Health, a New York City-based oncology technology company, has expanded its relationships with biotechnology company Celgene Corp. and biopharmaceutical company Amgen. Here are three things ...

Please provide your email address to receive an email when new articles are posted on . A viewpoint paper outlined the benefits of a well-coordinated patient-reported outcomes collection system. The ...

American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002 OBJECTIVE: ...

To develop a technology assessment of chemotherapy sensitivity and resistance assays in order to define the role of these tests in routine oncology practice. The American Society of Clinical Oncology ...

Brandt continued, "We are incredibly grateful for the dedication of our Radiation Therapists to our mission of providing the most effective nonsurgical treatment for basal and squamous cell skin ...